These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Anticoagulants and platelet-active agents in the secondary prevention of coronary artery disease. Van Aken WG Adv Cardiol; 1982; 31():98-101. PubMed ID: 6758512 [No Abstract] [Full Text] [Related]
3. Management of thrombotic diseases. Douglas AS Semin Hematol; 1971 Apr; 8(2):95-139. PubMed ID: 4396057 [No Abstract] [Full Text] [Related]
4. Platelets and antiplatelet therapy in ischemic heart disease. Frishman WH; Miller KP Curr Probl Cardiol; 1986 Feb; 11(2):69-136. PubMed ID: 2936576 [No Abstract] [Full Text] [Related]
5. Antithrombotic agents in coronary artery disease. Resnekov L; Chediak J; Hirsh J; Lewis D Chest; 1986 Feb; 89(2 Suppl):54S-67S. PubMed ID: 3510831 [No Abstract] [Full Text] [Related]
6. [Possibilities and limits of controlled clinical therapy studies for the demonstration of the effectiveness of antithrombotic therapy]. Loo J Folia Haematol Int Mag Klin Morphol Blutforsch; 1975; 102(2):172-94. PubMed ID: 50982 [No Abstract] [Full Text] [Related]
7. Antiplatelet and anticoagulant therapy in acute myocardial infarction. Jafri SM Henry Ford Hosp Med J; 1991; 39(3-4):195-9. PubMed ID: 1804824 [No Abstract] [Full Text] [Related]
8. [Prophylactic value of platelet anti-aggregants in coronary disease]. Verstraete M Clin Ter; 1979 Oct; 91(2):117-27. PubMed ID: 396098 [No Abstract] [Full Text] [Related]
10. Platelet-inhibitor therapy in cardiovascular disease. Effective defense against thromboembolism. Chesebro JH; Steele PM; Fuster V Postgrad Med; 1985 Jul; 78(1):48-50, 57-71. PubMed ID: 3160013 [TBL] [Abstract][Full Text] [Related]
11. [Treatment of myocardial infarct with anticoagulants, thrombolytics, inhibitors of platelet aggregation and beta receptor blockaders]. Thiele R Z Arztl Fortbild (Jena); 1984; 78(5):167-71. PubMed ID: 6202068 [No Abstract] [Full Text] [Related]
12. Antiplatelet aggregant agents and thrombolytic compounds in myocardial infarction: current status. Wessler S; Sherman LA Circulation; 1972 Apr; 45(4):911-8. PubMed ID: 4555190 [No Abstract] [Full Text] [Related]
13. Present status of antiaggregating agents in coronary and cerebrovascular disease prevention. Polli EE; Cortellaro M Haematologica; 1980 Jun; 65(3):361-9. PubMed ID: 6778788 [No Abstract] [Full Text] [Related]
14. [Platelet aggregation inhibitors in the prevention of myocardial infarction: the results of prospective studies]. Shalaev SV Kardiologiia; 1989 Sep; 29(9):116-20. PubMed ID: 2687554 [No Abstract] [Full Text] [Related]
15. [Current clinical results of antiplatelet medication]. Ordinas A Sangre (Barc); 1984; 29(4-C):833-40. PubMed ID: 6393391 [No Abstract] [Full Text] [Related]
16. [Correction of thrombophilia]. Caruzzo C; Marcolongo M; Arpino E; Di Summa M Minerva Cardioangiol; 1981; 29(1-2):13-8. PubMed ID: 6112717 [No Abstract] [Full Text] [Related]
19. Effect of drugs of platelets and complications of vascular disease. Mustard JF; Packham MA; Kinlough-Rathbone RL Adv Exp Med Biol; 1977; 82():94-105. PubMed ID: 920448 [No Abstract] [Full Text] [Related]
20. Antiplatelet agents: their role in the prevention of sudden death. Hirsh J Ann N Y Acad Sci; 1982; 382():289-304. PubMed ID: 7044244 [No Abstract] [Full Text] [Related] [Next] [New Search]